1Takeda M, Ito W, Tanabe M, et at, The pathophysiological roles of PI3Ks and therapeutic potential of selective inhibitors in allergic in- flammation[J]. Int Arch Allergy Immunol, 2010, 152( 1 ) : 90 -95.
2Bosse Y, Chin LY, Pare PD, et al. Adaptation of airway smooth mus- cle to basal tone[ J]. Am J Respir Cell Mel Bio1,2009 ,40 :13 - 18.
3Hakim RK, Metz M, Maurer M. Mast cells: makers and breakers of' allergic inflammation[ J]. Curr Opin Allergy Clin Inmmno1,2009,9: 427 - 430.
4Boyce JA, Broide D, Matsumoto K, et at. Advances in mechanisms of asthma, allergy, and immunology in 2008 [ J ]. J Allergy Clin Im- muno1,2009 ,123 :569 - 574.
5Endo D, Con Y, Nunomura S, et at. PI3K:, differentially regulates FceR1 mediated degranulation and migration of mast ceils by and to- ward antigen[ J]. Int Arch Allergy Immunol,2009,149:66 -72.
6Uddin M, Nong G, Ward J, et aL Prosurvival activity for airway neu- trophils in severe asthma [ J ]. Thorax,2010,65:684 - 689.
7Lim DH, Cho JY, Song DJ, et al. PI3K gamma - deficient mice have reduced levels of allergen - induced eosinophilic inf lamination and airway remodeling [ J ]. Am J Physiol Lung Cell Mol Physiol, 2009, 296:210 - 219.
